BAKER BROS. ADVISORS LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Kodiak Sciences Inc. 13D/A Amendment 12 KOD · 50015M109	KOD	50015M109	35.0%	22,049,297	13D/A Amendment 12	9/30/2026 Event 9/28/2026
Baker Bros. Advisors LP			35.0%	22,049,297
Baker Bros. Advisors (GP) LLC			35.0%	22,049,297
Julian C. Baker			35.0%	22,049,297
Felix J. Baker			35.0%	22,049,297
BeOne Medicines Ltd. 13D/A Amendment 14 ONC · 07725L102	ONC	07725L102	7.8%	115,912,814	13D/A Amendment 14	9/16/2026 Event 9/14/2026
Baker Bros. Advisors LP			7.8%	115,457,154
Baker Bros. Advisors (GP) LLC			7.8%	115,457,154
Julian C. Baker			7.8%	115,912,814
Felix J. Baker			7.8%	115,912,814
FBB3 LLC			<0.1%	144,517
IDEAYA Biosciences, Inc. 13G IDYA · 45166A102	IDYA	45166A102	5.2%	5,010,030	13G	8/14/2026 Event 6/30/2026
Baker Bros. Advisors LP			5.2%	5,010,030
Baker Bros. Advisors (GP) LLC			5.2%	5,010,030
Julian C. Baker			5.2%	5,010,030
Felix J. Baker			5.2%	5,010,030
Revolution Medicines, Inc. 13G RVMD · 76155X100	RVMD	76155X100	5.3%	11,443,357	13G	8/14/2026 Event 6/30/2026
Baker Bros. Advisors LP			5.3%	11,443,357
Baker Bros. Advisors (GP) LLC			5.3%	11,443,357
Julian C. Baker			5.3%	11,443,357
Felix J. Baker			5.3%	11,443,357
Immatics N.V. 13G/A Amendment 6 IMTX · N44445109	IMTX	N44445109	7.0%	9,508,565	13G/A Amendment 6	8/14/2026 Event 6/30/2026
Baker Bros. Advisors LP			7.0%	9,508,565
Baker Bros. Advisors (GP) LLC			7.0%	9,508,565
Julian C. Baker			7.0%	9,508,565
Felix J. Baker			7.0%	9,508,565
Edgewise Therapeutics, Inc. 13G/A Amendment 2 EWTX · 28036F105	EWTX	28036F105	3.4%	3,701,719	13G/A Amendment 2	8/14/2026 Event 6/30/2026
Baker Bros. Advisors LP			3.4%	3,701,719
Baker Bros. Advisors (GP) LLC			3.4%	3,701,719
Julian C. Baker			3.4%	3,701,719
Felix J. Baker			3.4%	3,701,719
Cerus Corporation 13G/A Amendment 13 CERS · 157085101	CERS	157085101	3.2%	6,415,295	13G/A Amendment 13	8/14/2026 Event 6/30/2026
Baker Bros. Advisors LP			3.2%	6,395,431
Baker Bros. Advisors (GP) LLC			3.2%	6,395,431
Julian C. Baker			3.2%	6,415,295
Felix J. Baker			3.2%	6,415,295
Replimune Group, Inc. 13D/A Amendment 1 REPL · 76029N106	REPL	76029N106	11.8%	11,075,336	13D/A Amendment 1	8/11/2026 Event 8/9/2026
Baker Bros. Advisors LP			11.8%	11,075,336
Baker Bros. Advisors (GP) LLC			11.8%	11,075,336
Julian C. Baker			11.8%	11,075,336
Felix J. Baker			11.8%	11,075,336
Celcuity Inc. 13G CELC · 15102K100	CELC	15102K100	10.0%	4,877,963	13G	7/16/2026 Event 7/14/2026
Baker Bros. Advisors LP			10.0%	4,877,963
Baker Bros. Advisors (GP) LLC			10.0%	4,877,963
Julian C. Baker			10.0%	4,877,963
Felix J. Baker			10.0%	4,877,963
Celcuity Inc. 13D/A Amendment 2 CELC · 15102K100	CELC	15102K100	10.0%	4,877,963	13D/A Amendment 2	7/16/2026 Event 7/14/2026
Baker Bros. Advisors LP			10.0%	4,877,963
Baker Bros. Advisors (GP) LLC			10.0%	4,877,963
Julian C. Baker			10.0%	4,877,963
Felix J. Baker			10.0%	4,877,963
BeOne Medicines Ltd. 13D/A Amendment 13 ONC · 07725L102	ONC	07725L102	8.0%	115,912,814	13D/A Amendment 13	6/15/2026 Event 6/11/2026
Baker Bros. Advisors LP			8.0%	115,457,154
Baker Bros. Advisors (GP) LLC			8.0%	115,457,154
Julian C. Baker			8.0%	115,912,814
Felix J. Baker			8.0%	115,912,814
FBB3 LLC			<0.1%	144,517
Kiniksa Pharmaceuticals International, plc 13D/A Amendment 6 KNSA · G52694109	KNSA	G52694109	7.0%	3,253,341	13D/A Amendment 6	5/26/2026 Event 5/21/2026
Baker Bros. Advisors LP			6.9%	3,231,181
Baker Bros. Advisors (GP) LLC			6.9%	3,231,181
Julian C. Baker			7.0%	3,253,341
Felix J. Baker			7.0%	3,253,341
FBB3 LLC			<0.1%	7,320
Monte Rosa Therapeutics, Inc. 13G/A Amendment 2 GLUE · 61225M102	GLUE	61225M102	10.0%	8,876,346	13G/A Amendment 2	5/15/2026 Event 3/31/2026
Baker Bros. Advisors LP			10.0%	8,876,346
Baker Bros. Advisors (GP) LLC			10.0%	8,876,346
Julian C. Baker			10.0%	8,876,346
Felix J. Baker			10.0%	8,876,346
GRAIL, Inc. 13G/A Amendment 2 GRAL · 384747101	GRAL	384747101	9.8%	4,028,614	13G/A Amendment 2	5/15/2026 Event 3/31/2026
Baker Bros. Advisors LP			9.8%	4,028,614
Baker Bros. Advisors (GP) LLC			9.8%	4,028,614
Julian C. Baker			9.8%	4,028,614
Felix J. Baker			9.8%	4,028,614
KALA BIO, Inc. 13G/A Amendment 2 KALA · 483119301	KALA	483119301	<0.1%	2,312	13G/A Amendment 2	5/15/2026 Event 3/31/2026
Baker Bros. Advisors LP			<0.1%	2,312
Baker Bros. Advisors (GP) LLC			<0.1%	2,312
Julian C. Baker			<0.1%	2,312
Felix J. Baker			<0.1%	2,312
Praxis Precision Medicines, Inc. 13G PRAX · 74006W207	PRAX	74006W207	6.3%	1,753,198	13G	5/15/2026 Event 3/31/2026
Baker Bros. Advisors LP			6.3%	1,753,198
Baker Bros. Advisors (GP) LLC			6.3%	1,753,198
Julian C. Baker			6.3%	1,753,198
Felix J. Baker			6.3%	1,753,198
Incyte Corp 13D/A Amendment 33 INCY · 45337C102	INCY	45337C102	15.6%	31,225,572	13D/A Amendment 33	5/11/2026 Event 5/7/2026
Baker Bros. Advisors LP			15.4%	30,865,077
Baker Bros. Advisors (GP) LLC			15.4%	30,865,077
Julian C. Baker			15.6%	31,223,155
Felix J. Baker			15.6%	31,225,572
FBB2, LLC			<0.1%	14,755
FBB3 LLC			<0.1%	31,140
FBB Associates			<0.1%	33,410
AbCellera Biologics Inc. 13G/A Amendment 2 ABCL · 00288U106	ABCL	00288U106	10.8%	33,012,138	13G/A Amendment 2	5/7/2026 Event 4/30/2026
Baker Bros. Advisors LP			10.8%	33,012,138
Baker Bros. Advisors (GP) LLC			10.8%	33,012,138
Julian C. Baker			10.8%	33,012,138
Felix J. Baker			10.8%	33,012,138
Prelude Therapeutics Inc 13D/A Amendment 5 PRLD · 74065P101	PRLD	74065P101	15.5%	10,295,301	13D/A Amendment 5	4/22/2026 Event 4/20/2026
Baker Bros. Advisors LP			15.5%	10,295,301
Baker Bros. Advisors (GP) LLC			15.5%	10,295,301
Julian C. Baker			15.5%	10,295,301
Felix J. Baker			15.5%	10,295,301
BeOne Medicines Ltd. (f/k/a BeiGene Ltd.) 13D/A Amendment 12 ONC · 07725L102	ONC	07725L102	8.0%	115,918,313	13D/A Amendment 12	4/16/2026 Event 4/16/2026
Baker Bros. Advisors LP			8.0%	115,462,653
Baker Bros. Advisors (GP) LLC			8.0%	115,462,653
Julian C. Baker			8.0%	115,918,313
Felix J. Baker			8.0%	115,918,313
FBB3 LLC			<0.1%	144,517
Celcuity Inc. 13D/A Amendment 1 CELC · 15102K100	CELC	15102K100	20.0%	9,582,874	13D/A Amendment 1	3/24/2026 Event 3/20/2026
Baker Bros. Advisors LP			20.0%	9,582,874
Baker Bros. Advisors (GP) LLC			20.0%	9,582,874
Julian C. Baker			20.0%	9,582,874
Felix J. Baker			20.0%	9,582,874
ACADIA Pharmaceuticals Inc. 13D/A Amendment 17 ACAD · 004225108	ACAD	004225108	25.4%	43,294,373	13D/A Amendment 17	2/26/2026 Event 2/24/2026
Baker Bros. Advisors LP			25.3%	43,151,054
Baker Bros. Advisors (GP) LLC			25.3%	43,151,054
Julian C. Baker			25.4%	43,294,373
Felix J. Baker			25.4%	43,294,373
FBB3 LLC			<0.1%	40,443
GRAIL, Inc. 13G GRAL · 384747101	GRAL	384747101	5.3%	2,085,333	13G	2/17/2026 Event 12/31/2025
Baker Bros. Advisors LP			5.3%	2,085,333
Baker Bros. Advisors (GP) LLC			5.3%	2,085,333
Julian C. Baker			5.3%	2,085,333
Felix J. Baker			5.3%	2,085,333
Alkermes plc. 13G ALKS · G01767105	ALKS	G01767105	6.1%	10,012,267	13G	2/17/2026 Event 12/31/2025
Baker Bros. Advisors LP			6.1%	10,012,267
Baker Bros. Advisors (GP) LLC			6.1%	10,012,267
Julian C. Baker			6.1%	10,012,267
Felix J. Baker			6.1%	10,012,267
KALA BIO, Inc. 13G/A Amendment 1 KALA · 483119202	KALA	483119202	10.0%	2,890,055	13G/A Amendment 1	2/17/2026 Event 12/31/2025
Baker Bros. Advisors LP			10.0%	2,890,055
Baker Bros. Advisors (GP) LLC			10.0%	2,890,055
Julian C. Baker			10.0%	2,890,055
Felix J. Baker			10.0%	2,890,055
Revolution Medicines, Inc. 13G/A Amendment 1 RVMD · 76155X100	RVMD	76155X100	4.9%	9,455,357	13G/A Amendment 1	2/17/2026 Event 12/31/2025
Baker Bros. Advisors LP			4.9%	9,455,357
Baker Bros. Advisors (GP) LLC			4.9%	9,455,357
Julian C. Baker			4.9%	9,455,357
Felix J. Baker			4.9%	9,455,357
Nurix Therapeutics, Inc. 13G/A Amendment 4 NRIX · 67080M103	NRIX	67080M103	7.2%	7,527,996	13G/A Amendment 4	2/17/2026 Event 12/31/2025
Baker Bros. Advisors LP			7.2%	7,527,996
Baker Bros. Advisors (GP) LLC			7.2%	7,527,996
Julian C. Baker			7.2%	7,527,996
Felix J. Baker			7.2%	7,527,996
Stoke Therapeutics, Inc. 13G/A Amendment 1 STOK · 86150R107	STOK	86150R107	5.8%	3,336,697	13G/A Amendment 1	2/17/2026 Event 12/31/2025
Baker Bros. Advisors LP			5.8%	3,336,697
Baker Bros. Advisors (GP) LLC			5.8%	3,336,697
Julian C. Baker			5.8%	3,336,697
Felix J. Baker			5.8%	3,336,697
Monte Rosa Therapeutics, Inc. 13G/A Amendment 1 GLUE · 61225M102	GLUE	61225M102	6.7%	4,345,736	13G/A Amendment 1	2/17/2026 Event 12/31/2025
Baker Bros. Advisors LP			6.7%	4,345,736
Baker Bros. Advisors (GP) LLC			6.7%	4,345,736
Julian C. Baker			6.7%	4,345,736
Felix J. Baker			6.7%	4,345,736
Incyte Corp 13D/A Amendment 32 INCY · 45337C102	INCY	45337C102	15.7%	31,213,417	13D/A Amendment 32	2/10/2026 Event 2/6/2026
Baker Bros. Advisors LP			15.5%	30,852,922
Baker Bros. Advisors (GP) LLC			15.5%	30,852,922
Julian C. Baker			15.7%	31,211,000
Felix J. Baker			15.7%	31,213,417
FBB2, LLC			<0.1%	14,755
FBB3 LLC			<0.1%	31,140
FBB Associates			<0.1%	33,410
DBV Technologies S.A. 13D/A Amendment 9 DBVT · 23306J309	DBVT	23306J309	10.0%	25,586,190	13D/A Amendment 9	1/14/2026 Event 1/12/2026
Baker Bros. Advisors LP			10.0%	25,586,190
Baker Bros. Advisors (GP) LLC			10.0%	25,586,190
Julian C. Baker			10.0%	25,586,190
Felix J. Baker			10.0%	25,586,190
Kodiak Sciences Inc. 13D/A Amendment 11 KOD · 50015M109	KOD	50015M109	32.8%	20,067,542	13D/A Amendment 11	12/19/2025 Event 12/18/2025
Baker Bros. Advisors LP			32.8%	20,067,542
Baker Bros. Advisors (GP) LLC			32.8%	20,067,542
Julian C. Baker			32.8%	20,067,542
Felix J. Baker			32.8%	20,067,542
Kymera Therapeutics, Inc. 13D/A Amendment 3 KYMR · 501575104	KYMR	501575104	10.9%	8,676,797	13D/A Amendment 3	12/11/2025 Event 12/9/2025
Baker Bros. Advisors LP			10.9%	8,676,797
Baker Bros. Advisors (GP) LLC			10.9%	8,676,797
Julian C. Baker			10.9%	8,676,797
Felix J. Baker			10.9%	8,676,797
Immatics N.V. 13G/A Amendment 5 IMTX · N44445109	IMTX	N44445109	10.0%	12,094,094	13G/A Amendment 5	11/14/2025 Event 9/30/2025
Baker Bros. Advisors LP			10.0%	12,094,094
Baker Bros. Advisors (GP) LLC			10.0%	12,094,094
Julian C. Baker			10.0%	12,094,094
Felix J. Baker			10.0%	12,094,094
Cerus Corporation 13G/A Amendment 12 CERS · 157085101	CERS	157085101	5.2%	10,028,209	13G/A Amendment 12	11/14/2025 Event 9/30/2025
Baker Bros. Advisors LP			5.2%	10,008,345
Baker Bros. Advisors (GP) LLC			5.2%	10,008,345
Julian C. Baker			5.2%	10,028,209
Felix J. Baker			5.2%	10,028,209
KALA BIO, Inc. 13G KALA · 483119202	KALA	483119202	10.0%	744,759	13G	10/3/2025 Event 10/2/2025
Baker Bros. Advisors LP			10.0%	744,759
Baker Bros. Advisors (GP) LLC			10.0%	744,759
Julian C. Baker			10.0%	744,759
Felix J. Baker			10.0%	744,759
KALA BIO, Inc. 13D/A Amendment 2 KALA · 483119202	KALA	483119202	10.0%	744,759	13D/A Amendment 2	10/2/2025 Event 9/30/2025
Baker Bros. Advisors LP			10.0%	744,759
Baker Bros. Advisors (GP) LLC			10.0%	744,759
Julian C. Baker			10.0%	744,759
Felix J. Baker			10.0%	744,759
IGM Biosciences, Inc. 13D/A Amendment 8 IGMS · 449585108	IGMS	449585108	0%	0	13D/A Amendment 8	8/18/2025 Event 8/14/2025
Baker Bros. Advisors LP			0%	0
Baker Bros. Advisors (GP) LLC			0%	0
Julian C. Baker			0%	0
Felix J. Baker			0%	0
Edgewise Therapeutics, Inc. 13G/A Amendment 1 EWTX · 28036F105	EWTX	28036F105	6.9%	7,305,940	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Baker Bros. Advisors LP			6.9%	7,305,940
Baker Bros. Advisors (GP) LLC			6.9%	7,305,940
Julian C. Baker			6.9%	7,305,940
Felix J. Baker			6.9%	7,305,940
Immatics N.V. 13G/A Amendment 4 IMTX · N44445109	IMTX	N44445109	8.4%	10,168,901	13G/A Amendment 4	8/14/2025 Event 6/30/2025
Baker Bros. Advisors LP			8.4%	10,168,901
Baker Bros. Advisors (GP) LLC			8.4%	10,168,901
Julian C. Baker			8.4%	10,168,901
Felix J. Baker			8.4%	10,168,901
Neurogene Inc. 13G/A Amendment 1 NGNE · 64135M105	NGNE	64135M105	7.0%	991,804	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Baker Bros. Advisors LP			7.0%	991,691
Baker Bros. Advisors (GP) LLC			7.0%	991,691
Julian C. Baker			7.0%	991,804
Felix J. Baker			7.0%	991,804
Revolution Medicines, Inc. 13G RVMD · 76155X100	RVMD	76155X100	5.0%	9,364,972	13G	8/14/2025 Event 6/30/2025
Baker Bros. Advisors LP			5.0%	9,364,972
Baker Bros. Advisors (GP) LLC			5.0%	9,364,972
Julian C. Baker			5.0%	9,364,972
Felix J. Baker			5.0%	9,364,972
Cerus Corporation 13G/A Amendment 11 CERS · 157085101	CERS	157085101	6.8%	12,903,708	13G/A Amendment 11	8/14/2025 Event 6/30/2025
Baker Bros. Advisors LP			6.7%	12,883,844
Baker Bros. Advisors (GP) LLC			6.7%	12,883,844
Julian C. Baker			6.8%	12,903,708
Felix J. Baker			6.8%	12,903,708
Celcuity Inc. 13D CELC · 15102K100	CELC	15102K100	18.9%	7,745,692	13D	8/1/2025 Event 8/1/2025
Baker Bros. Advisors LP			18.9%	7,745,692
Baker Bros. Advisors (GP) LLC			18.9%	7,745,692
Julian C. Baker			18.9%	7,745,692
Felix J. Baker			18.9%	7,745,692
Kymera Therapeutics, Inc. 13D/A Amendment 2 KYMR · 501575104	KYMR	501575104	9.5%	6,666,540	13D/A Amendment 2	6/30/2025 Event 6/26/2025
Baker Bros. Advisors LP			9.5%	6,666,540
Baker Bros. Advisors (GP) LLC			9.5%	6,666,540
Julian C. Baker			9.5%	6,666,540
Felix J. Baker			9.5%	6,666,540
Prelude Therapeutics Inc 13D/A Amendment 4 PRLD · 74065P101	PRLD	74065P101	23.5%	10,269,968	13D/A Amendment 4	6/13/2025 Event 6/12/2025
Baker Bros. Advisors LP			23.5%	10,269,968
Baker Bros. Advisors (GP) LLC			23.5%	10,269,968
Julian C. Baker			23.5%	10,269,968
Felix J. Baker			23.5%	10,269,968
Candel Therapeutics, Inc. 13G/A Amendment 1 CADL · 137404109	CADL	137404109	4.99%	2,455,108	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Baker Bros. Advisors LP			4.99%	2,455,108
Baker Bros. Advisors (GP) LLC			4.99%	2,455,108
Julian C. Baker			4.99%	2,455,108
Felix J. Baker			4.99%	2,455,108
Neurogene Inc. 13G NGNE · 64135M105	NGNE	64135M105	10.0%	1,486,313	13G	5/15/2025 Event 3/31/2025
Baker Bros. Advisors LP			10.0%	1,486,200
Baker Bros. Advisors (GP) LLC			10.0%	1,486,200
Julian C. Baker			10.0%	1,486,313
Felix J. Baker			10.0%	1,486,313
Rhythm Pharmaceuticals, Inc. 13G/A Amendment 7 RYTM · 76243J105	RYTM	76243J105	8.9%	5,604,483	13G/A Amendment 7	5/15/2025 Event 3/31/2025
Baker Bros. Advisors LP			8.9%	5,604,483
Baker Bros. Advisors (GP) LLC			8.9%	5,604,483
Julian C. Baker			8.9%	5,604,483
Felix J. Baker			8.9%	5,604,483
Celcuity Inc. 13G/A Amendment 2 CELC · 15102K100	CELC	15102K100	11.3%	4,257,735	13G/A Amendment 2	4/7/2025 Event 3/31/2025
Baker Bros. Advisors LP			11.3%	4,257,735
Baker Bros. Advisors (GP) LLC			11.3%	4,257,735
Julian C. Baker			11.3%	4,257,735
Felix J. Baker			11.3%	4,257,735
DBV Technologies S.A. 13D/A Amendment 8 DBVT · 23306J309	DBVT	23306J309	17.1%	23,489,663	13D/A Amendment 8	3/31/2025 Event 3/27/2025
Baker Bros. Advisors LP			17.1%	23,489,663
Baker Bros. Advisors (GP) LLC			17.1%	23,489,663
Julian C. Baker			17.1%	23,489,663
Felix J. Baker			17.1%	23,489,663
Replimune Group, Inc. 13D REPL · 76029N106	REPL	76029N106	14.3%	11,045,336	13D	3/7/2025 Event 3/7/2025
Baker Bros. Advisors LP			14.3%	11,045,336
Baker Bros. Advisors (GP) LLC			14.3%	11,045,336
Julian C. Baker			14.3%	11,045,336
Felix J. Baker			14.3%	11,045,336
Sera Prognostics, Inc. 13D SERA · 81749D107	SERA	81749D107	16.1%	5,498,170	13D	2/14/2025 Event 2/12/2025
Baker Bros. Advisors LP			16.1%	5,498,170
Baker Bros. Advisors (GP) LLC			16.1%	5,498,170
Julian C. Baker			16.1%	5,498,170
Felix J. Baker			16.1%	5,498,170
Immatics N.V. 13G/A Amendment 3 IMTX · N44445109	IMTX	N44445109	6.0%	7,275,830	13G/A Amendment 3	2/14/2025 Event 12/31/2024
Baker Bros. Advisors LP			6.0%	7,275,830
Baker Bros. Advisors (GP) LLC			6.0%	7,275,830
Julian C. Baker			6.0%	7,275,830
Felix J. Baker			6.0%	7,275,830
Celcuity Inc. 13G/A Amendment 1 CELC · 15102K100	CELC	15102K100	7.2%	2,678,553	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Baker Bros. Advisors LP			7.2%	2,678,553
Baker Bros. Advisors (GP) LLC			7.2%	2,678,553
Julian C. Baker			7.2%	2,678,553
Felix J. Baker			7.2%	2,678,553
Candel Therapeutics, Inc. 13G CADL · 137404109	CADL	137404109	6.8%	2,981,983	13G	2/14/2025 Event 12/31/2024
Baker Bros. Advisors LP			6.8%	2,981,983
Baker Bros. Advisors (GP) LLC			6.8%	2,981,983
Julian C. Baker			6.8%	2,981,983
Felix J. Baker			6.8%	2,981,983
Biomea Fusion, Inc. 13G/A Amendment 2 BMEA · 09077A106	BMEA	09077A106	4.0%	1,451,990	13G/A Amendment 2	2/14/2025 Event 12/31/2024
Baker Bros. Advisors LP			4.0%	1,451,990
Baker Bros. Advisors (GP) LLC			4.0%	1,451,990
Julian C. Baker			4.0%	1,451,990
Felix J. Baker			4.0%	1,451,990
KALA BIO, Inc. 13D/A Amendment 1 KALA · 483119202	KALA	483119202	19.7%	1,201,894	13D/A Amendment 1	12/31/2024 Event 12/29/2024
Baker Bros. Advisors LP			19.7%	1,201,894
Baker Bros. Advisors (GP) LLC			19.7%	1,201,894
Julian C. Baker			19.7%	1,201,894
Felix J. Baker			19.7%	1,201,894